Allon Therapeutics, Inc. announced that Mr. Michael Aldridge, Director of the company since June 2011, has resigned to accept a new professional responsibility in the biotech industry.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | +9,900.00% |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 14.11K | |
+41.79% | 54.04B | |
+45.94% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- NPCUF Stock
- News Allon Therapeutics Inc.
- Michael Aldridge Resigns as Director of Allon Therapeutics, Inc